A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Intensity Therapeutics, Inc.
Pfizer
Pfizer
Stanford University
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
Roswell Park Cancer Institute
Fox Chase Cancer Center
Curis, Inc.
National Institutes of Health Clinical Center (CC)